SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 113,410.19 |
| Enterprise Value ($M) | 134,510.19 |
| Book Value ($M) | 18,390.00 |
| Book Value / Share | 14.76 |
| Price / Book | 6.17 |
| NCAV ($M) | -23,076.00 |
| NCAV / Share | -18.52 |
| Price / NCAV | -4.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.00 |
| Return on Assets (ROA) | 0.00 |
| Return on Equity (ROE) | 0.01 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.82 |
| Current Ratio | 1.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 13,059.00 |
| Assets | 54,525.00 |
| Liabilities | 36,135.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 8.97 | -0.19 | |
| 13G/A | Capital World Investors | 6.70 | 21.48 | |
| 13G/A | BlackRock, Inc. | 9.90 | -6.66 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 525,472 | 5,681,237 | 9.25 | |
| 569,188 | 5,233,726 | 10.88 | |
| 486,219 | 4,395,976 | 11.06 | |
| 815,215 | 5,977,828 | 13.64 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FGEN – FibroGen, Inc. | GBIO – Generation Bio Co. |
| GERN – Geron Corporation | GLUE – Monte Rosa Therapeutics, Inc. |
| GOSS – Gossamer Bio, Inc. |